BevacizumabReferencesCitationsHurwitz H, et al. (2004). Bevacizumab plus irinotecan,
fluorouracil, and leucovorin for metastatic colorectal cancer. New England Journal of Medicine, 350(23):
2335–2342. U.S. Food and Drug Administration (2006). FDA approves new combination therapy for lung cancer. FDA News. Available online: http://www.fda.gov/bbs/topics/NEWS/2006/NEW01488.html.
| | Author: | Douglas Dana Shannon Erstad, MBA/MPH | Last Updated: March 19, 2007 | | Medical Review: | Adam Husney, MD - Family Medicine Jerome B. Simon, MD, FRCPC, FACP - Gastroenterology Arvydas D. Vanagunas, MD - Gastroenterology | © 1995-2008 Healthwise, Incorporated. Healthwise, Healthwise for every health decision, and the Healthwise logo are trademarks of Healthwise, Incorporated.This information does not replace the advice of a doctor. Healthwise disclaims any warranty or liability for your use of this information. Your use of this information means that you agree to the Terms of Use. How this information was developed to help you make better health decisions.
| 
| |
| |